GLADNEY DAN W
Known title: DirectorCIK: 0001224184
Associated companies
Transaction History
| HIND | ▼ Sell | Open Market | 200,000 | $598K | 9/10/2021 | View on chart |
| HIND | ▲ Buy | Grant | 483,922 | $0 | 7/22/2021 | View on chart |
| HIND | ▼ Sell | Open Market | 200,000 | $598K | 9/10/2021 | View on chart |
| HIND | ▲ Buy | Grant | 483,922 | $0 | 7/22/2021 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
Vyome Holdings Gets USPTO Patent Allowance for VT-1908
Vyome Holdings received a USPTO notice of allowance for a U.S. patent covering its VT-1908 topical mycophenolate program. This development relates to a treatment targeting the ocular inflammation market, which is valued at over $20 billion. The stock is currently trading near its 52-week low, with analysts averaging a higher target price.
Vyome Holdings Gets USPTO Patent Allowance for VT-1908. Vyome Holdings received a USPTO notice of allowance for a U.S. patent covering its VT-1908 topical mycophenolate program. This development relates to a treatment targeting the ocular inflammation market, which is valued at over $20 billion. The stock is currently trading near its 52-week low, with analysts averaging a higher target price.